NOV's 1-year price change of +43.5% reflects a sustained uptrend from its 52-week low of $11.78, but the stock has pulled back sharply from its 52-week high of $21.55. The current price of $18.66 sits at 73% of the 52-week range, indicating it has given back some gains but remains well above the lows. This positioning suggests the stock is in a corrective phase within a longer-term uptrend, offering a potential entry point if support holds. Over the past 1 month, NOV has declined 7.8%, while the 3-month change is -6.1%, showing accelerating short-term weakness. This contrasts with the strong 1-year gain, creating a divergence that could signal a mean-reversion bounce or a deeper correction. The 1-month relative strength vs. SPY is -4.9%, underperforming the market, while the 1-year relative strength remains positive at +24.4%, indicating the long-term trend is still intact. The 52-week low of $11.78 provides key support, while resistance sits at the 52-week high of $21.55. A breakout above $21.55 would signal a resumption of the uptrend, while a breakdown below $11.78 would negate the long-term bullish structure. With a beta of 0.91, NOV is slightly less volatile than the overall market, meaning its moves are roughly in line with SPY but with a defensive tilt.

NOV's revenue trajectory has been choppy, with the most recent quarter (Q4 2025) reporting $2.277 billion, down 1.3% year-over-year from $2.308 billion in Q4 2024. Over the past four quarters, revenue has ranged from $2.103 billion to $2.277 billion, showing stagnation rather than growth. The Q4 2025 YoY decline of -1.3% and the sequential drop from Q3 2025's $2.176 billion indicate a deceleration, likely reflecting softer oilfield activity. This lack of top-line growth is a concern for the investment case, as it suggests limited pricing power or volume expansion. The company reported a net loss of -$78 million in Q4 2025, swinging from a net income of $160 million in Q4 2024, a significant deterioration. Gross margin remained relatively stable at 20.3% in Q4 2025 vs. 21.4% a year ago, but operating margin compressed to 7.1% from 9.0%, and net margin turned negative at -3.4%. The trailing twelve-month net income was positive at $145 million (sum of last four quarters), but the Q4 loss highlights earnings volatility. Compared to industry peers, NOV's gross margin of ~20% is typical for oilfield equipment manufacturers, but the negative net margin in Q4 is below the sector average. NOV's balance sheet appears healthy with a debt-to-equity ratio of 0.37 and a current ratio of 2.42, indicating ample liquidity. Free cash flow for the trailing twelve months was $876 million, providing strong cash generation to fund operations and dividends. The ROE of 2.3% is low, reflecting modest profitability relative to equity, but the FCF yield of 15.1% (FCF/market cap) is attractive. The company has $1.552 billion in cash at the end of Q4 2025, up from $1.207 billion at the start of the year, suggesting no near-term financing concerns.